Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details)

v3.23.1
Stockholders' Equity (Cantor Fitzgerald Underwriting and RubrYc Transaction) (Narrative) (Details) - USD ($)
1 Months Ended
Sep. 19, 2022
Aug. 17, 2022
Mar. 31, 2023
Nov. 25, 2020
Subscription receivable     $ 260,000  
RubrYc Therapeutics, Inc. [Member]        
Sale of preferred stock $ 1,000,000      
Number of shares issued 102,354      
Sales Agreement | Cantor Fitzgerald [Member]        
Aggregate offering price       $ 100,000,000
Number of shares issued   1,551,879    
Proceeds from sale of shares, net of issuance cost   $ 2,900,000